(Q40128143)

English

Prevalence of K65R in patients treated with tenofovir disoproxil fumarate: recommendations based on the Frankfurt HIV Cohort Study Resistance Database (FHCS-RD).

scientific article published on 8 January 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26746222%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Prevalence of K65R in patients treated with tenofovir disoproxil fumarate: recommendations based on the Frankfurt HIV Cohort Study Resistance Database (FHCS-RD) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26746222%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

based on heuristic

inferred from title

author name string

Claudia Reinheimer

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26746222%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Anna Wesner

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26746222%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Oliver T Keppler

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26746222%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Eva Herrmann

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26746222%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Christoph Stephan

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26746222%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

8 January 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26746222%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Medical Microbiology and Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26746222%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

205

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26746222%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26746222%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

315-320

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26746222%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

https://scigraph.springernature.com/pub.10.1007/s00430-015-0448-4

0 references

Extensive implementation of highly active antiretroviral therapy shows great effect on survival and surrogate markers in vertically HIV-infected children

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Analysis of HIV- type 1 protease and reverse transcriptase in Brazilian children failing highly active antiretroviral therapy (HAART).

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Antiretroviral drug resistance mutations in the reverse transcriptase gene of HIV-1 isolates from Northern Indian patients: a follow-up study.

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Community HIV-1 drug resistance is associated with transmitted drug resistance

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

HIV-1 subtypes and drug resistance profiles in a cohort of heterosexual patients in Istanbul, Turkey

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Molecular epidemiology of HIV in a cohort of men having sex with men from Istanbul.

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Long-Term Efficacy, Safety, and Tolerability of Indinavir-Based Therapy in Protease Inhibitor--Naive Adults with Advanced HIV Infection

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Genotypic and phenotypic analyses of HIV-1 in antiretroviral-experienced patients treated with tenofovir DF.

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Extended treatment with tenofovir disoproxil fumarate in treatment-experienced HIV-1-infected patients: genotypic, phenotypic, and rebound analyses

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Human immunodeficiency virus reverse transcriptase and protease sequence database

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Rationale and uses of a public HIV drug-resistance database

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Tenofovir resistance and resensitization

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

The lysine 65 residue in HIV-1 reverse transcriptase function and in nucleoside analog drug resistance

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

K65R mutation of human immunodeficiency virus type 1 reverse transcriptase encodes cross-resistance to 9-(2-phosphonylmethoxyethyl)adenine

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Improved virological and immunological efficacy of resistance-guided switch in antiretroviral therapy: a Frankfurt HIV cohort analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Description of two commercially available assays for genotyping of HIV-1.

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Modifications and substitutions of the RNA extraction module in the ViroSeq HIV-1 genotyping system version 2: effects on sensitivity and complexity of the assay.

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naive HIV patients

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/lamivudine + efavirenz administered on a multiple tablet therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio.

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Prevalence of the K65R resistance reverse transcriptase mutation in different HIV-1 subtypes in Israel.

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

High prevalence of the K65R mutation in HIV-1 subtype C infected patients failing tenofovir-based first-line regimens in South Africa

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Intensification of a failing regimen with zidovudine may cause sustained virologic suppression in the presence of resensitising mutations including K65R.

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutations

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

Rate of virologic failure and selection of drug resistance mutations using different triple nucleos(t)ide analogue combinations in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

A combination of decreased NRTI incorporation and decreased excision determines the resistance profile of HIV-1 K65R RT.

1 reference

https://api.crossref.org/works/10.1007%2FS00430-015-0448-4

21 January 2018

In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26746222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tenofovir disoproxil fumarate

1 reference

https://pubmed.ncbi.nlm.nih.gov/26746222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug Resistance Mutations in HIV-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/26746222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2014 Update of the drug resistance mutations in HIV-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/26746222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low prevalence of transmitted K65R and other tenofovir resistance mutations across different HIV-1 subtypes: implications for pre-exposure prophylaxis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26746222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

K65R, TAMs and tenofovir.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26746222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The K65R reverse transcriptase mutation in HIV-1 reverses the excision phenotype of zidovudine resistance mutations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26746222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiretroviral therapy in HIV-2-infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, Côte d'Ivoire

1 reference

https://pubmed.ncbi.nlm.nih.gov/26746222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV-1 antiretroviral drug therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26746222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evolution of the K65R, K103N and M184V/I reverse transcriptase mutations in HIV-1-infected patients experiencing virological failure between 2005 and 2010.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26746222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug resistance mutations in HIV-1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26746222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00430-015-0448-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26746222%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26746222%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40128143&oldid=1484398316"